Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

9.70
Delayed Data
As of Sep 23
 -0.04 / -0.41%
Today’s Change
7.02
Today|||52-Week Range
20.36
-39.45%
Year-to-Date

Today’s Trading

Previous close9.74
Today’s open9.73
Day’s range9.53 - 9.86
Volume195,269
Average volume (3 months)396,031
Market cap$562.2M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-98.80%
Earnings growth (this year)+34.34%
Earnings growth (next 5 years)--
Revenue growth (last year)-93.82%
P/E ratioNM
Price/Sales249.31
Price/Book2.39

Competitors

 Today’s
change
Today’s
% change
PDLIPDL BioPharma Inc+0.08+2.39%
BLCMBellicum Pharmaceuti...+1.26+6.53%
ATRAAtara Biotherapeutic...-0.34-1.66%
MCRBSeres Therapeutics I...-0.14-1.03%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$2.6M
Annual profit (last year)-$132.4M
Net profit margin-5,170.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert B. Bazemore
Chief Operating Officer
Matthew E. Ros
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Search for Jobs